Autolus Therapeutics AUTL
NASDAQ AUTL
$1.78 -0.07 (-3.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Gross Profit (2024 - 2026)

Updated

Autolus Therapeutics (AUTL) reported Gross Profit of $25.22 million for Q2 2026, compared with -$3.52 million a year earlier.

Analysis

Autolus Therapeutics (AUTL) Gross Profit (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Autolus Therapeutics' Gross Profit came in at $13.21 million; for FY2025, it was -$20.98 million.

  • By year, Gross Profit came in at -$1.27 million in FY2024 and $1.7 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Autolus Therapeutics 631.98 Mn -692.11 Mn 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.22 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -3.52 Mn
Mar 31, 2025 -8.97 Mn
Dec 31, 2024 -11.36 Mn
Mar 31, 2024 10.09 Mn
API Access

Autolus Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=AUTL&period=max&api_key=YOUR_API_KEY